Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPL | P05186 | 11/20 | 0.48 |
| ▸ | RAF1 | P04049 | 1/20 | 0.34 |
| ▸ | MTOR | P42345 | 4/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.30 |
| ▸ | MET | P08581 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19138494 | 1.00 | ALPL (0.48) | ALPLRAF1MTORPIK3CAMET | |
| SCHEMBL19138436 | 1.00 | ALPL (0.48) | ALPLRAF1MTORPIK3CAMET | |
| SCHEMBL19138429 | 0.79 | ALPL (0.46) | ALPL | |
| SCHEMBL19138439 | 0.79 | ALPL (0.46) | ALPL | |
| SCHEMBL19138410 | 0.74 | ALPL (0.47) | ALPLRAF1 | |
| SCHEMBL19138423 | 0.72 | ALPL (0.48) | ALPLRAF1 | |
| SCHEMBL21801973 | 0.72 | ALPL (0.49) | ALPL | |
| SCHEMBL30538722 | 0.71 | ALPL (0.54) | ALPL | |
| SCHEMBL19138421 | 0.71 | MEN1 (0.42) | ALPL | |
| SCHEMBL21801979 | 0.70 | ALPL (0.52) | ALPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3319970-B1 | PYRIDO-OXAZINONE DERIVATIVES AS TNAP INHIBITORS | DAIICHI SANKYO CO LTD (JP) | 2019-08-28 | — | — | EP | disclosed |
| US-10221195-B2 | Pyridine compounds | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2019-03-05 | — | — | US | disclosed |
| US-20180141960-A1 | PYRIDINE COMPOUNDS | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2018-05-24 | — | — | US | disclosed |
| US-9920068-B2 | Pyridine compounds | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2018-03-20 | — | — | US | disclosed |
| US-9879032-B2 | Pyridine compounds | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2018-01-30 | — | — | US | disclosed |
| US-20170240562-A1 | PYRIDINE COMPOUNDS | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2017-08-24 | — | — | US | disclosed |
| US-20170210755-A1 | PYRIDINE COMPOUNDS | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2017-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180141960-A1 | PYRIDINE COMPOUNDS | ALPI, ALPP, ALPL | ALPL 3/4885RAF1 1675/4885MTOR 3318/4885 |
| US-20170240562-A1 | PYRIDINE COMPOUNDS | ALPI, ALPP, ALPL | ALPL 3/4885RAF1 1675/4885MTOR 3318/4885 |
| US-10221195-B2 | Pyridine compounds | ALPI, ALPP, ALPL | ALPL 3/4885RAF1 1675/4885MTOR 3318/4885 |
| US-20170210755-A1 | PYRIDINE COMPOUNDS | ALPI, ALPP, ALPL | ALPL 3/4885RAF1 1675/4885MTOR 3318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.